Tandem Diabetes Care | TNDM - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Abbott USD 1.85B 399M 2026-03
Accuray USD 4.71M 6.86M 2024-12
Align Technology USD 178.05M 46.66M 2026-03
AtriCure USD 526K 1.96M 2026-03
Baxter International USD 66M 280.2M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Boston Scientific USD 1.05B 190M 2026-03
Cooper Companies USD -31M 243.8M 2026-03
Dexcom USD 255.3M 67.7M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Globus Medical USD 164M 17.31M 2026-03
ICU Medical USD 26.09M 770K 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 122M 24.3M 2026-03
Integra LifeSciences USD 11.47M 54.54M 2026-03
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.03B 2026-03
Medtronic USD 2.09B 354M 2026-03
Merit Medical Systems USD 44.16M 10.04M 2026-03
Orthofix International USD 6.12M 1.91M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Stryker USD 1.1B 867M 2026-03
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 37.03M 686K 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03